Product correctly added to cart.

discount label
3,4-Dehydro cilostazol
View 3D

Biosynth logo

3,4-Dehydro cilostazol

CAS: 73963-62-9

Ref. 3D-FD20902

10mg
102.00 €
25mg
134.00 €
50mg
183.00 €
100mg
270.00 €
250mg
502.00 €
Estimated delivery in United States, on Thursday 8 Aug 2024

Product Information

Name:
3,4-Dehydro cilostazol
Synonyms:
  • 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinoneOPC 13015
Description:

3,4-Dehydro cilostazol is a selective inhibitor of cyclic nucleotide phosphodiesterase III (PDEIII). It has been shown to be effective in cases of hepatic impairment, and its pharmacokinetic properties have been studied in human liver. 3,4-Dehydro cilostazol has shown to increase the concentration of cyclic adenosine monophosphate (cAMP) levels in plasma and urine samples. 3,4-Dehydro cilostazol may cause drug interactions with other drugs that are substrates for PDEIII or that have an effect on the metabolism of endogenous substances.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
367.45 g/mol
Formula:
C20H25N5O2
Purity:
Min. 95%
InChI:
InChI=1S/C20H25N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h9-12,14,16H,1-8,13H2,(H,21,26)
InChI key:
InChIKey=GHALECSGOJQOHW-UHFFFAOYSA-N
SMILES:
O=c1ccc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2[nH]1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FD20902 3,4-Dehydro cilostazol

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".